PANC-PALS
@Panc_pals
Followers
275
Following
14
Media
19
Statuses
60
The PANC-PALS consortium is committed to providing a platform where pancreatologists can collaborate, share their expertise, and advance patient care ๐ค ๐๐๐
Join the PANC-PALS registry ๐
Joined August 2022
Two important randomized trials in #PancreaticCancer published: 1st PASS-01 in metastatic cancer comparing FOLFIRINOX to Gem/Abraxane (@JCO_ASCO) 2nd PREOPANC-2 in resectable/borderline resectable cancer comparing neoadjuvant FFX versus Gem/CRT (@TheLancetOncol) @OncoAlert โฌ๏ธ
1
60
146
New birthday, new city, new job, new beginnings! ๐ฅณ Delighted to start in my new role at @nyulangone @Perlmutter_CC. Looking forward to establishing a vibrant GI cancer center with @DrMhidalgo @JohnPLeonardMD & other exceptional colleagues. โค๏ธ my commute - view from my window!
46
13
343
Throwback to @PancreasClub ๐ Honored to present PANC-PALS Collaborator-led consortium and global registry ๐ช๐ป๐ช๐ป Thank you for everyoneโs hard work to get IRBs and contracts signed ๐๐งโ๐ป
0
1
12
What a pleasure to host University of Padova PANC-PALS local PI, @Gio_Marchegiani, at our HQ this week! ๐ Great discussions followed by a drink by the East River ๐ #PANCPALS
2
3
35
๐ to @NYULH_Surgery 2๏ธโฃ2๏ธโฃ years after!!! In 2003 I had the best time as a med student... ๐ฃ Such a honor to be hosted by this amazing team ๐ชก Surgery for LAPC: complex arterial / venous resections by Chris Wolfgang and Katherine Morgan + many projects with @ammar_asrar ongoing
2
3
80
Published in #BJC, our ๐ study with 935 localized #pancreaticancer patients after resection, comparing preoperative FFX vs GnP: ๐FFX vs. GnP not associated with OS (p=0.17) ๐Effect FFX โฌ๏ธ if lower serum CA19.9 #tumorbiology ๐จPragmatic RCT #chemosensitivitymarkers ๐
1
6
15
@FlavioRochaMD @SWOG @UWSurgery @fredhutch @PancreasClub @PanCAN @NatPancFdn @Panc_pals @YouppiePancreas @OHSUKnight @SyedAAhmad5 @TheNotoriousHPB @HalletJulie @PaulKaranicolas @laleh_melstrom @AGangiMD @PatrickJWorth @HPB_Surgeon @skmaithel @DenboJw @ALLIANCE_org institutions are excited to support and enroll! S2408 also presented today at the GI Surgery Working Group Spring Meeting! #Collaboration is #Key โฌ๏ธPOPF โฌ๏ธ Patient Quality of Life @theNCI @PancreasClub @ISGPS_news
@NRGonc @eaonc @NCICancerTrials @ShamSurgery
0
3
8
Drop by our #PANCPALS booth at @PancreasClub this weekend, and get your lanyard! ๐๐ป ๐
0
2
13
0
4
16
Pancreatic cancer, often linked to smoking, obesity and diabetes, is predicted to become the 2nd leading cause of cancer-related death by 2030. A recent Seminar discusses the need for novel therapies & future directions for research: https://t.co/IQNCCl8FJY
8
124
286
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study โฆ@BJSurgeryโฉ
academic.oup.com
In this international retrospective cohort study from the Trans-Atlantic Pancreatic Surgery Consortium, the independent prognostic factors for overall surv
0
16
27
The seminar series from @TheLancet are always excellent and this one from @MarcBesselink and colleagues is no exception. #PancreaticCancer
Pancreatic cancer, often linked to smoking, obesity and diabetes, is predicted to become the 2nd leading cause of cancer-related death by 2030. A recent Seminar discusses the need for novel therapies & future directions for research: https://t.co/IQNCCl8FJY
0
5
14
Neoadjuvant chemo ๐ค๐ค surgery for Resectable PDAC ๐ฏ๐ต RCT ๐ Gemcitabine + S1 median OS 37 months vs. 26 ๐ก Is neoadjuvant chemo extending survival over upfront surgery?! ๐ค What are your thoughts?! ๐ญ https://t.co/2gqnxVpYVH
2
33
90
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX โฆ@JAMAOncโฉ โฆ@MarcBesselinkโฉ
jamanetwork.com
This cohort study investigates the association of adjuvant chemotherapy following resection of pancreatic adenocarcinoma after preoperative FOLFIRINOX in full or modified dosing with overall surviv...
0
9
34
๐จNew publication! ๐จ A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! ๐๐ช๐ป๐๐ผ https://t.co/h42NIbKeak
0
4
12
โผ๏ธCA 19-9 DELTA FUNCTION ๐ dynamic evaluation over NAT ๐๐ป 1๏ธโฃ value never tells the full story ๐๐ป ๐ซ๐ท๐บ๐ธ๐ฎ๐น๐ณ๐ฑ๐ฌ๐ง So proud to be part of this squad @Panc_pals
https://t.co/tOSk4ehIkv mฮดf ๐งฎ available at
journals.lww.com
tic CA19-9 values or percentage changes often fail to capture therapeutic responses in patients with BR-PC undergoing NAT. Improved evaluation methods are essential for guiding the treatment....
1
2
10
Staying hydrated everywhere with our #PANCPALS waterbottle ๐๐ช๐ป Progressing with contracts, and looking forward to our Azure platformโฆ soon to be ready ๐ฉ๐ผโ๐ป๐ง๐ฝโ๐ป Stay tuned for updates! ๐๐ค
0
1
3
An absolutely honor to work with this amazing team to put this work together! Would not have been possible without @TFStoopโs heavy ๐๏ธ and @MarcBesselinkโs leadership!
Published in @TheLancet, our review on #PancreaticCancer ๐Epidemiology๐ ๐Pathogenesis๐ฌ ๐Risk factors & surveillance๐ต๏ธ ๐Diagnostics๐ฉบ ๐Treatment๐ ๐Future directions๐ โฆ by @ammar_asrar, @ObaAtsushi, T. Seufferlein, JW Wilmink, @BasGrootKoerkam & @MarcBesselink
0
1
21
We are honored to see the #PANCPALS consortium expanding the last few weeks! Already over 80 committed sites globally, and still growing ๐ช๐ Join us now! Find the joining questionnaire on https://t.co/CgwN5d83KD
0
3
9